MeSH Browser

MeSH Heading: beta-Galactoside alpha-2,3-Sialyltransferase
Tree Number(s): D08.811.913.400.800.500
Unique ID: D000094663
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000094663
Scope Note: Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 3-OH of the GALACTOSE residue of N-GLYCANS.
Entry Term(s): Asialofetuin Sialyltransferase; CMP N-Acetylneuraminate-beta-Galactoside alpha-2,3-Sialyltransferase; CMP-ANGS-Transferase; CMP-Acetylneuraminate-Galactoside (alpha 2-3)-Sialyltransferase; CMP-Neu5Ac-GAl beta1-3GalNAc alpha-2,3-Sialyltransferase; CMP-Neu5Ac-Gal1-3GalNAc alpha-2,3-Sialyltransferase; CMP-NeuAc-Galactoside (alpha 2-3)-Sialyltransferase; CMPSialic Acid beta-Galactosyl-1-3-N-Acetylgalactosaminide alpha 2-3-Sialyltransferase; Gal beta1,3GalNAc alpha2,3-Sialyltransferase; ST3Gal I; ST3Gal II; ST3Gal III; ST3Gal IV; ST3Gal VI; alpha 2-3-Sialyltransferase; alpha-2,3-ST(O); beta-D-Galactoside 3-alpha-Sialyltransferase
Registry Numbers: EC 2.4.99.4; EC 2.4.99.4; EC 2.4.99.9; EC 2.4.99.-; EC 2.4.99.4; EC 2.4.99.4; EC 2.4.99.4
Related Numbers: EC 2.4.99.-; EC 2.4.99.4; EC 2.4.99.9
Public MeSH Note: 2023; was indexed as SIALYLTRANSFERASES 1982-2022
History Note: 2023
Date Established: 2023/01/01
Date of Entry: 2022/07/13
Revision Date: 2022/07/12

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

beta-Galactoside alpha-2,3-Sialyltransferase MeSH Descriptor Data 2024